|
ATP5C1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.97865000000075E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.81330000000158E-05 |
| Normal-vs-Stage2 |
5.670400E-01 |
| Normal-vs-Stage3 |
6.42480000312418E-08 |
| Normal-vs-Stage4 |
1.23710000021759E-08 |
| Stage1-vs-Stage2 |
4.661100E-03 |
| Stage1-vs-Stage3 |
2.883600E-02 |
| Stage1-vs-Stage4 |
3.821000E-03 |
| Stage2-vs-Stage3 |
3.009200E-04 |
| Stage2-vs-Stage4 |
8.49470000000574E-05 |
| Stage3-vs-Stage4 |
4.396000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.17210000039059E-07 |
| Normal-vs-AfricanAmerican |
1.128490E-02 |
| Normal-vs-Asian |
4.578700E-04 |
| Caucasian-vs-AfricanAmerican |
3.752400E-01 |
| Caucasian-vs-Asian |
4.617800E-01 |
| AfricanAmerican-vs-Asian |
7.671000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.169900E-04 |
| Normal-vs-Female |
1.95548999999406E-05 |
| Male-vs-Female |
6.340400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.374600E-04 |
| Normal-vs-Age(41-60Yrs) |
1.56487999999344E-05 |
| Normal-vs-Age(61-80Yrs) |
1.981900E-02 |
| Normal-vs-Age(81-100Yrs) |
5.563500E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.950000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.045600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.277600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.051900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.539600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.693800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.296000E-03 |
| Classical-VS-Follicular |
1.47539758188486E-11 |
| Classical-VS-Other |
3.972000E-01 |
| Classical-VS-Normal |
1.05020003804412E-09 |
| Tall-VS-Follicular |
1.704525409707E-12 |
| Tall-VS-Other |
2.015200E-01 |
| Tall-VS-Normal |
3.7706948674554E-11 |
| Follicular-VS-Other |
9.102200E-02 |
| Follicular-VS-Normal |
6.882100E-02 |
| Other-VS-Normal |
1.134970E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.964820E-03 |
| Normal-vs-N1 |
9.00799990155576E-10 |
| N0-vs-N1 |
2.18249999999198E-05 |
|
|
